Previous Article | Next Article ![]()
Infect. Immun., Jan 1998, 52-58, Vol 66, No. 1
MS Donnenberg, CO Tacket, G Losonsky, G Frankel, JP Nataro, G Dougan and MM Levine
Two studies of adult volunteers were performed to determine whether prior
enteropathogenic Escherichia coli (EPEC) infection confers protective
immunity against rechallenge. In the first study, a naive control group and
volunteers who had previously ingested an O55:H6 strain were fed an O127:H6
strain. In the second study, a control group and volunteers who had
previously ingested either the O127:H6 strain or an isogenic eae deletion
mutant of that strain were challenged with the homologous wild-type strain.
There was no significant effect of prior infection on the incidence of
diarrhea in either study. However, in the homologous-rechallenge study,
disease was significantly milder in the group previously challenged with
the wild-type strain. Disease severity was inversely correlated with the
level of prechallenge serum immunoglobulin G against the O127
lipopolysaccharide. These studies indicate that prior EPEC infection can
reduce disease severity upon homologous challenge. Further studies may
require the development of new model systems.
Copyright © 1998, American Society for Microbiology
Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201, USA. mdonnenb@umabnet.ab.umd.edu
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»